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Axonopathies are a group of clinically diverse disorders characterized by the progressive degeneration of the 
axons of specific neurons. In hereditary spastic paraplegia (HSP), the axons of cortical motor neurons degen-
erate and cause a spastic movement disorder. HSP is linked to mutations in several loci known collectively as 
the spastic paraplegia genes (SPGs). We identified a heterozygous receptor accessory protein 1 (REEP1) exon 2 
deletion in a patient suffering from the autosomal dominantly inherited HSP variant SPG31. We generated the 
corresponding mouse model to study the underlying cellular pathology. Mice with heterozygous deletion of 
exon 2 in Reep1 displayed a gait disorder closely resembling SPG31 in humans. Homozygous exon 2 deletion 
resulted in the complete loss of REEP1 and a more severe phenotype with earlier onset. At the molecular level, 
we demonstrated that REEP1 is a neuron-specific, membrane-binding, and membrane curvature–inducing 
protein that resides in the ER. We further show that Reep1 expression was prominent in cortical motor neu-
rons. In REEP1-deficient mice, these neurons showed reduced complexity of the peripheral ER upon ultra-
structural analysis. Our study connects proper neuronal ER architecture to long-term axon survival.
Introduction
Axons are elaborate subcellular structures: once established, they 
comprise most of the cell’s volume (up to 99% in motor neurons) 
and account for most of its membrane surface. Yet, the synthesis 
of structural and functional components largely takes place in the 
soma (1). As a consequence, lifelong maintenance of axon integrity 
imposes a great challenge to neurons and requires the concerted 
action of numerous cellular components and processes. In line with 
this notion, various genetic defects lead to axon degeneration, while 
the parent cell bodies and dendrites are spared. Taken together, such 
axonopathies are among the most common hereditary diseases (2).
A length-dependent degeneration of cortical motor neuron 
axons results in a spastic gait disorder in hereditary spastic para-
plegias (HSPs) (3). With more than 40 spastic paraplegia gene 
(SPG) loci described and more than 20 genes already identified, 
HSP is genetically highly heterogeneous (4). HSP is therefore con-
sidered a model disease for unraveling the various requirements 
for long-term axon survival (5). The cellular functions of HSP 
genes and the molecular pathomechanisms, however, are only 
beginning to be understood (5–7).
SPG31 represents an autosomal dominant HSP and is caused by 
mutations in REEP1 (8). Based on the truncating nature of most 
mutations, a loss-of-function mechanism has been suggested 
(9, 10) but not yet proven. REEP1 belongs to a gene family that 
consists of two subfamilies in vertebrates (REEP1-REEP4 and 
REEP5-REEP6) and a single ancestral gene in yeast (YOP1) (11). 
REEP proteins contain two hydrophobic regions, and the more 
C-terminal domain (the “REEP domain”) defines the family and is 
substantially longer than conventional transmembrane domains. 
Similar regions are found in the evolutionarily unrelated caveolins, 
reggie/flottilins, and reticulons (12). They have been suggested 
to insert as hairpins into one leaflet of cellular membranes and 
to mediate intramembrane homo- and heteromeric interactions 
(11, 13). Hairpin-like membrane insertion has been proposed as 
a mechanism for curvature generation, curvature stabilization, 
and/or curvature sensing, specifically in the peripheral ER (14–17). 
With regard to REEPs, current knowledge is largely based on in 
vitro assays with REEP5, on overexpression in cell lines, and on 
genetic manipulation of the yeast ortholog Yop1p (11, 13–16, 
18). Loss-of-function approaches in multicellular organisms and 
detailed characterization of the consequences are not yet available.
In order to unravel the pathophysiology caused by mutations in 
REEP1 in vivo, we modeled SPG31 in mice. This resulted in REEP1 
dose-dependent phenotypes and pathologies closely resembling 
those seen in HSP patients. At the subcellular level, we observed 
a reduced complexity of the peripheral ER in cortical motor neu-
rons. Together with in vitro evidence for REEP1 in the induction 
of positive membrane curvature, our study connects impaired ER 
shaping to a failure in maintaining long axons.
Results
Absence of REEP1 exon 2 is associated with a spastic paraplegia phenotype in 
both humans and mice. Upon screening HSP patients for mutations in 
REEP1, multiplex ligation–dependent probe amplification (MLPA) 
suggested a heterozygous absence of exon 2 in a patient with a fam-
ily history of pure, early-onset disease (Figure 1A). Long-range PCR 
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revealed that exon 2 plus flanking intronic sequences are deleted and 
suggested nonhomologous end-joining of adjacent double-strand 
breaks as the mutational mechanism (Figure 1B). The lack of exon 2 
in REEP1 mRNA is predicted to create a preterminal stop codon 
in exon 3 (Supplemental Figure 1; supplemental material available 
online with this article; doi:10.1172/JCI65665DS1).
In order to study the pathophysiology of REEP1-associated HSP, 
we modeled the exon 2 deletion in mice (Figure 1C and Supple-
mental Figure 1). The effects at the protein level were examined 
with an antibody obtained from the immunization of rabbits 
against a C-terminal REEP1 epitope (Supplemental Figure 2). 
Whereas a band of the appropriate size was recognized in brain 
lysates of wild-type (Reep1+/+) mice, anti-REEP1 immunoreactiv-
ity was absent in mice homozygous for the Reep1 exon 2 deletion 
(Reep1–/–). This finding confirmed the specificity of the antibody, 
revealed a lack of REEP1 upon exon 2 deletion, and characterized 
the mutation as representing a knockout allele (Figure 1D).
Mating of heterozygous mice (Reep1+/–) resulted in offspring of 
all three genotypes at Mendelian ratios. Whereas young Reep1+/– 
and Reep1–/– mice could not be distinguished from Reep1+/+ mice 
by visual examination, the hind limbs of Reep1–/– mice older than 
12 months were abnormally abducted during locomotion, with 
extreme external rotation of the paws. Moreover, the animals 
frequently displayed simultaneous forward movements of both 
hind limbs (Supplemental Video 1). At rest, the trunk and tail 
were not lifted, and the paws contacted the ground with most of 
their plantar surface (Figure 1E) rather than showing ordinary toe 
placement. REEP1-deficient mice also showed spastic clonus upon 
a skilled walking challenge such as climbing an inclined ladder 
(Supplemental Video 2).
The combination of weakness and spasticity of the hind limbs, 
together with the apparent sparing of the forelimbs, strongly resem-
bles the clinical symptoms of human HSP patients and thereby 
defines our REEP1 knockout mice as a clinically valid disease model.
Figure 1
Lack of REEP1 exon 2 is associated with spastic paraplegia in humans and causes a severe motor phenotype in mice. (A) MLPA-based screening 
of genomic DNA from an HSP index patient for copy number alterations in REEP1. The assay targets exons 3–6 with single probes, and exons 
1, 2, and 7 with 2 or 3 probes each (ex1-1, ex1-2, etc.). Relative MLPA signals of approximately 1.0 indicate a normal diploid copy number (gray 
bars), whereas signals of approximately 0.5 (black bars) indicate a heterozygous genomic deletion. (B) Alignment of REEP1 intron 1 and intron 
2 sequences with the sequence of the fusion allele. The box highlights the microhomology of 3 bp at the junction and the exclamation points 
denote nucleotide identity. (C) Strategy of Reep1 exon 2 deletion in mice. Wild-type locus (top schematic); the thick horizontal line marks the 
genomic region used for the targeting construct. The targeted locus is shown in the middle schematic, and the targeted locus after Cre-mediated 
exon 2 excision is shown in the bottom schematic. Numbered black squares: exons; triangles: loxP sites; NEO: neomycin selection cassette; 
BamHI, EcoRI, SmaI, SalI: restriction sites used for cloning. (D) Western blot analysis of brain lysates from Reep1+/+ and Reep1–/– mice using 
affinity-purified anti-REEP1 antibodies shows the absence of REEP1 protein in Reep1–/– mice. (E) Sixteen-month-old Reep1–/– mice suffer from 
gait abnormalities (see also Supplemental Videos 1 and 2). Note the broad-based positioning of the hind limbs, the kyphotic posture, and that 
neither the hind body nor the tail is properly lifted.
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Gait impairment in REEP1-deficient mice progresses with age and is char-
acterized by axonal degeneration in the spinal cord. We quantified the 
extent and progression of the movement phenotype in our mouse 
model by measuring the foot-base angle over time. A significant 
decrease was first observed in 16-week-old Reep1–/– mice. Notably, 
Reep1+/– animals were affected as well, but with later onset and to 
a lesser degree. At 20 weeks of age, both Reep1–/– and Reep1+/– mice 
showed strong impairments (Figure 2, A and B).
Figure 2
The REEP1 knockout phenotype is progressive, dose-dependent, and associated with a neurodegenerative rather than a neurodevelopmental 
pathology of upper motor neuron axons. (A) Measurement of the foot-base angle. Shown are images of 20-week-old mice immediately prior 
to hind paw lifting. (B) Genotype dependence of foot-base angle over time. Error bars represent the SEM. *P < 0.05 (two-way ANOVA). (C) 
Semithin sections of the corticospinal tract in the spinal cord of 30-week-old mice at the lumbar level. Arrow and asterisk denote pathological 
structures, which are interspersed between morphological intact axons of Reep1–/– but not Reep+/+ mice. Scale bars: 1 μm. (D) Ultrastructural 
characterization of pathologies as highlighted in C. Dark structures are packed with electron-dense material (left panel); vacuolar structures are 
regions devoid of cellular material (right panel). The presence of myelin sheaths (arrowheads) indicates an axonal origin. Scale bars: 400 nm. 
(E) Neuronal cell bodies in the motor cortices of 13-month-old Reep1+/+ and Reep1–/– mice were identified by NeuN immunoreactivity. Scale 
bars: 200 μm. (F) Layer-wise quantification revealed no neuron loss in Reep1–/– mice. Error bars represent the SEM. (G) Lower motor neurons 
are not involved as judged from CMAPs upon sciatic nerve stimulation recorded from the musculus triceps surae. Error bars represent the 
SEM. (H) Cortical neurons obtained from P1 pups and cultured for 3 days. Neurites were visualized with phalloidin (Phl). Axons were labeled 
by the pan-axonal neurofilament marker SMI312 (SMI). Scale bars: 50 μm. (I) Quantification of the length of the longest axonal projection of 
each neuron. Error bars represent the SEM.
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Cross sections of the spinal cord at lumbar levels in 30-week-old 
Reep1–/– mice revealed evidence of corticospinal tract axon degen-
eration (Figure 2, C and D). There was, however, no loss of cortical 
motor neuron somata even at 13 months of age (Figure 2, E and F).
Considering the lower motor neuron involvement in the SPG7 
mouse model (19, 20) and in patients carrying a toxic gain-of-
function REEP1 allele (21), we measured compound muscle action 
potentials (CMAPs) in the musculus triceps surae, as alterations in 
this parameter have been correlated with preclinical loss of spinal 
cord motor neuron axons in a mouse model for amyotrophic lat-
eral sclerosis (22). Supporting the finding that lower motor neu-
rons were not affected, CMAPs in Reep+/– and Reep1–/– animals did 
not differ from those in Reep1+/+ controls even 10 weeks after the 
onset of gait impairment (Figure 2G).
In order to address whether axon outgrowth is impaired in the 
absence of REEP1, we isolated cortical neurons from P1 mice and 
spinal cord motor neurons from E12.5 embryos and quantified 
the axon length after 3 (cortical neurons) or 5 (spinal cord motor 
neurons) days in culture, respectively. There was no evidence of 
shorter axons or abnormal axon morphologies in neurons isolated 
from Reep1–/– mice (Figure 2, H and I, and Supplemental Figure 3).
Based on the adult onset of the phenotype, its progressive and 
degenerative rather than developmental nature, and the restriction 
of the defect to upper motor neuron axons, we conclude that the 
REEP1-deficient mouse is a valid model to study the pathophysi-
ology behind axon loss in SPG31.
Reep1 expression is neuron specific and particularly prominent in upper 
motor neurons. Radioactive whole-mount in situ hybridization on 
sagittal mouse sections revealed that Reep1 transcripts are already 
expressed during embryonic development and are confined to the 
nervous system (Figure 3A and Supplemental Figure 4).
Consistent with these findings, REEP1 protein was detected 
in brain lysates but not in lysates of any of several other tissues 
analyzed (Figure 3B, left panel). Moreover, a REEP1-derived signal 
was present in lysates of mixed neuronal glial cell cultures, but 
was absent from lysates of pure glial cell cultures (Figure 3B, right 
panel), indicating that REEP1 is specific to neurons.
Since our antibody did not detect endogenous REEP1 in immuno-
fluorescence studies, we performed nonradioactive in situ hybrid-
izations in order to define Reep1 expression in the brain at the cel-
lular level. The particularly strong labeling of cells in layer V of the 
primary motor cortex in coronal brain sections suggests a predom-
inant expression of Reep1 in upper motor neurons (Figure 3, C–F).
The phenotype and pathology of the REEP1 knockout as 
defined above are therefore consistent with both the tissue and 
cell specificity of Reep1 expression.
REEP1 associates with cellular membranes and is enriched in the ER. 
REEP1 contains two hydrophobic domains that have been pro-
posed to mediate membrane association (23). Its intracellular 
localization, however, has been controversial. Reports have 
included plasma membrane (23), mitochondria (8), or ER (11) 
localization of REEP1. In protein lysates prepared from mouse 
brain, we detected REEP1 exclusively in a crude membrane frac-
tion, but not in the cytosolic or mitochondrial fractions (Figure 
4A). In subfractions of the postmitochondrial fraction, REEP1 
detection overlapped with the tubular ER marker reticulon 4 
(RTN4) (16) rather than with the trans-Golgi marker γ-adaptin 
(ref. 24 and Figure 4, B and C).
Figure 3
Reep1 expression is neuron specific and particularly strong in cortical upper motor neurons. (A) Autoradiography of in situ hybridization of an 
E18.5 murine sagittal embryo section using a Reep1-specific probe. ca, caudal; cr, cranial; d, dorsal; v, ventral. Scale bar: 3 mm. (B) Western blot 
analyses of lysates of several organs from 4-month-old wild-type mice show REEP1 expression in the brain. Lysates from primary cortical cultures 
(P1) reveal expression in neurons but not in glial cells. (C) Schematic of a coronal section of an adult mouse brain at bregma +0.7 mm. cc, corpus 
callosum; cx, cortex; lv, lateral ventricle. Box depicts area displayed in D and E. (D) Nissl staining of a section of a 4-month-old wild-type mouse. 
pma, primary motor area; sma, secondary motor area. Arrowheads show the area borders. Scale bars: 500 μm. (E) In situ hybridization with a 
Reep1-specific probe on the section adjacent to the section shown in D. Scale bar: 500 μm. (F) Magnification of the primary motor area. Note the 
particularly strong labeling of cells in layer V of the primary motor cortex (i.e., upper motor neurons). Scale bar: 200 μm.
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These observations suggest a localization of REEP1 to the ER 
and particularly to highly curved ER compartments.
Liposome binding by REEP1 increases membrane curvature in vitro. 
As the central hydrophobic domain of REEP1 is unusually long 
and may serve as a hydrophobic wedge that is inserted into one 
leaflet of lipid bilayers to induce positive membrane curvature, 
we incubated liposomes with purified REEP1. We used recombi-
nant N-terminally HisTrx-tagged REEP1 (HisTrx-REEP1) and a 
mutant, in which the hydrophobic residues I57, F58, F62, and F64 
in the REEP domain were each exchanged by the polar amino acid 
serine (HisTrx-REEP1-mut). Both proteins, but not the HisTrx 
control, floated with liposomes into fraction 2 of density-gradient 
centrifugations (Figure 5, A and B).
In order to reveal the putative membrane-shaping activity of 
REEP1, snap-frozen protein-liposome suspensions were freeze-frac-
tured, and the liposome size was determined by transmission elec-
tron microscopy (TEM). The diameters of liposomes incubated with 
tagged or N-terminally untagged REEP1 were drastically reduced 
compared with the HisTrx control (Figure 5, C–E, and Supplemen-
tal Figure 5). Specifically, a group of liposomes with diameters of 
only 30 ± 10 nm that was virtually absent in the control incubations 
was very prominent upon incubation with REEP1 (Figure 5D).
This size-reduction effect was strongly diminished in incubations 
with HisTrx-REEP1-mut (Figure 5, C–E), indicating that the hydro-
phobic residues I57, F58, F62, and F64 of the REEP domain are 
critical in promoting membrane curvature. Further supporting its 
role in active membrane shaping, REEP1 was preferentially local-
ized at the surface of small-diameter liposomes (Figure 5F). More-
over, live imaging of protein-liposome suspensions clearly showed 
that liposome size remained stable over time upon the addition 
of the HisTrx control, whereas the addition of HisTrx-REEP1 rap-
idly induced constrictions and conversion of large liposomes into 
smaller ones (Figure 5G and Supplemental Videos 3 and 4). Consis-
tent data were obtained with N-terminally untagged REEP1 (Sup-
plemental Figure 5E and Supplemental Videos 5 and 6).
These observations suggest that REEP1 association with mem-
branes promotes their positive curvature, and that this REEP1 
function requires the integrity of the REEP domain.
REEP1 knockout mice show a dose-dependent reduction in the com-
plexity of the peripheral ER in cortical motor neurons. Considering (a) 
the phenotypical consequences of REEP1 deficiency; (b) the neu-
ron-specific expression of the gene; (c) the ER association of the 
protein; and (d) its membrane-shaping properties, we hypothe-
sized that REEP1 may play a critical role in proper organization 
of the neuronal ER, which consists of the nuclear envelope and 
its peripheral components. Both subcompartments were evalu-
ated in ultrastructural sections of layer V neurons of the primary 
motor cortex (Figure 6A).
Regarding the nucleus, neither the total length of the nuclear 
membrane (Figure 6B), the sphericity of the nuclear section (Fig-
ure 6C), nor the number of nuclear pockets per section (Figure 6D) 
showed any differences between genotypes.
Likewise, there was no difference in the cumulative length of 
peripheral ER structures (Figure 6E). The length of the individ-
ual structures, however, showed a statistically significant increase 
in Reep1–/– mice (Figure 6F). This gain in length was paralleled by 
statistically significant reductions in the number of peripheral ER 
structures in both Reep1+/– and Reep–/– mice (Figure 6G).
These findings at the ultrastructural level imply that REEP1 
deficiency has no effect on the nuclear portion of the ER. Instead, 
the observation of fewer but longer structures in the peripheral ER 
suggests that the complexity of this second subcompartment nega-
tively correlates with the amount of REEP1 available in the neuron.
Discussion
The aim to better characterize the factors that are important for 
axonal maintenance prompted us to model SPG31 in mice. Based 
on our identification of a deletion of exon 2 in REEP1 in a patient 
suffering from HSP, we removed the corresponding exon 2 in mice 
by a Cre-lox strategy. The deletion causes a frame shift resulting 
in a Reep1 knockout allele, which was confirmed by the absence 
of REEP1 protein in brain lysates of homozygously targeted mice. 
During early adulthood, Reep1+/– mice developed a progressive 
movement disorder of the hind limbs with weakness, spasticity, 
and degeneration of axons of the corticospinal tract mirroring 
the human SPG31 phenotype. Homozygous Reep1–/– mice became 
symptomatic 4 weeks earlier and were more severely affected, but 
the restriction of the pathology to upper motor neurons was pre-
served. The correlation between the phenotype and the number 
of knockout alleles establishes loss of function as the leading 
pathomechanism in REEP1-related HSP and suggests that HSP 
in patients with other REEP1 mutations also reflect loss of func-
Figure 4
REEP1 is enriched in cellular membranes that contain the ER protein RTN4. (A) Immunoblotting of subcellular fractions of murine brain lysates. 
TIM23: mitochondrial marker; actin served as a loading control. (B) Western blot analyses of REEP1, RTN4, and γ-adaptin after further sub-
fractionation of the REEP1-containing postmitochondrial fractions using iodixanol-gradient centrifugation. (C) Quantification of the data shown 
in B (n = 4). REEP1 cofractionates with the ER marker RTN4 but not with γ-adaptin, a marker for the trans-Golgi. Error bars represent the SEM.
research article
4278 The Journal of Clinical Investigation   http://www.jci.org   Volume 123   Number 10   October 2013
tion and not dominant-negative effects of truncated or mutated 
REEP1 protein variants.
There have been conflicting data regarding the sites of Reep1 
expression. While some have reported ubiquitous expression 
(8), others exclusively detected Reep1 in the brain (23). Here, we 
demonstrate that Reep1, though expressed throughout the ner-
vous system, shows particularly strong expression in cell bodies 
of upper motor neurons in cortical layer V. This is consistent with 
the main pathology seen in pure HSP. From our Western blot anal-
ysis of cultured neurons and glial cells, we further conclude that 
the REEP1 protein is neuron specific. In contrast, SPAST, which is 
mutated in SPG4 and is associated with a similar phenotype and 
pathology to that of REEP1, has a much broader expression (25). 
Regarding the developmental pattern of Reep1 expression, its tran-
Figure 5
REEP1 binds and curves membranes in vitro. (A) Constructs used for liposome-binding assays. The hydrophobic region encompassing resi-
dues 39–78 of REEP1 is marked (gray box). The positions of hydrophobic residues mutated to serines in HisTrx-REEP1-mut are indicated. (B) 
Liposome cofloatation assays. Proteins were detected using anti-HisTrx antibodies in immunoblots of sucrose gradient fractions 1 (top) to 6 
(bottom). Tagged REEP1 and REEP1-mut, but not the tag alone, floated with liposomes in fraction 2. (C) TEM images of freeze-fractured incu-
bations of liposomes with the indicated recombinant proteins. Scale bars: 200 nm. (D) Distribution of liposome diameters observed by TEM of 
freeze-fractured liposome incubations. Note that incubation with REEP1 leads to a pronounced increase in the relative numbers of 20- to 40-nm 
structures, the frequencies of which are strongly diminished upon incubation with HisTrx-REEP1-mut and are largely absent in the control incu-
bations. (E) Box plots of the full set of data partially presented in C. Note that the y axis is logarithmic. ***P < 0.001 (one-way ANOVA). Boxes 
contain 50% of the values; minimal, maximal, and median values are marked by vertical lines. (F) High-resolution TEM analysis of freeze-fractured 
liposomes incubated with REEP1 and immunogold labeled for REEP1 shows REEP1 at positively curved membranes of predominantly small 
liposomes (arrows). Scale bar: 80 nm. (G) Sequential video frames of liposomes incubated with HisTrx control protein and HisTrx-REEP1 (taken 
from Supplemental Videos 3 and 4). Arrows indicate the constriction of a large liposome into two smaller, stronger curved membrane structures 
upon addition of HisTrx-REEP1. Scale bars: 5 μm.
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scripts were already abundant in the nervous system at embryonic 
stages, however, Reep1+/– and Reep1–/– mice developed normally and 
had neither motor deficits nor gross alterations of the brain or 
spinal cord axons in their first months of life. Moreover, axonal 
outgrowth in neurons cultured from REEP1-deficient mice was 
unaffected. Thus, REEP1 is most likely not crucial for brain and 
spinal cord development, which fits well with the lack of pheno-
types of REEP1 mutations in humans during early childhood and 
is consistent with the view that HSP generally manifests as a neu-
rodegenerative rather than a neurodevelopmental disease (26).
Regarding the subcellular distribution of REEP1, conflicting 
reports have been published, which can be attributed to difficul-
ties in the detection of endogenous REEP1. In agreement with 
overexpression studies in HEK293 and HeLa cells (11), our West-
ern blot analysis of subcellular fractions of brain lysates clearly 
shows that endogenous REEP1 is associated with ER membranes, 
whereas the mitochondria, where REEP1 was initially reported to 
localize (8), were devoid of REEP1.
Our in vitro reconstitution assays show that REEP1 directly 
associates with lipids. Since we used liposomes, i.e., reconstituted 
membranes, it can further be concluded that REEP1 is not only 
able to bind to lipid molecules, but can also very effectively associ-
ate with lipid bilayers. Since our assay was devoid of any other pro-
teins, it can furthermore be concluded that this high affinity for 
lipid bilayers does not reflect a signal-dependent transmembrane 
integration, but rather is inherent to REEP1.
The live microscopic analyses and quantitative examinations of 
in vitro reconstitutions further show that association of REEP1 
with membranes promotes positive membrane curvature, causing 
the constriction of liposomes and a corresponding substantial 
increase in the abundance of small-diameter liposome structures. 
In line with these data, REEP1 immunogold labeling was restricted 
to the surface of smaller liposomes. So far, curvature-promoting 
properties of ER proteins have been experimentally shown in retic-
ulons and REEP5/Yop1p (14, 16), which are characterized by the 
presence of paired hydrophobic domains with unusual lengths 
Figure 6
REEP1 deficiency results in a dose-dependent reduction of the complexity of the peripheral ER but not of the nuclear envelope in neurons in 
the primary motor cortex. (A) Representative TEM images of neuronal somata in the primary motor cortex of Reep+/+ and Reep1–/– mice. The 
cytoplasm is colored in yellow, the nucleus in blue, and the ER in red. Scale bars: 2 μm for whole-cell images and 400 nm for insets. (B–G) Quan-
titative evaluations (mean ± SEM) of nuclear envelope and peripheral ER parameters in TEM sections of neuronal somata in the primary motor 
cortex of Reep1+/+, Reep1+/–, and Reep1–/– mice (4 animals per genotype, 12 cells per animal). Neither the length of the nuclear envelope (B), 
its sphericity (C), nor the number of nuclear pockets observed per cell section (D) differed between genotypes. Although the sum of the length 
of all peripheral ER structures per cell section was unaltered (E), a REEP1 dose–dependent increase was observed in the average length of 
individual ER structures (F) associated with a decrease in the number of individual ER structures per cell section (G). *P < 0.05 (one-way ANOVA).
research article
4280 The Journal of Clinical Investigation   http://www.jci.org   Volume 123   Number 10   October 2013
loxP site was inserted approximately 1.2 kb upstream of exon 2, thereby 
destroying an EcoRI site. A PGK promoter–driven neomycin resistance cas-
sette flanked by loxP sites and preceded by an EcoRI site was inserted into 
an SmaI site 262 bp downstream of exon 2. The construct was electropo-
rated into R1 mouse ES cells. Neomycin-resistant clones were analyzed by 
Southern blotting of EcoRI-digested ES cell DNA. Correctly targeted ES 
cells were transfected with a plasmid expressing Cre recombinase. Recom-
bination events removing exon 2 as well as the neomycin resistance cas-
sette were identified upon Southern blotting of EcoRI-digested genomic 
DNA. One of the positive clones was injected into C57BL6 blastocysts. 
The resulting chimeras were subsequently backcrossed with C57BL6 to 
obtain Reep1+/– mice. Studies were performed with littermates of the F4 
generation. Genotypes were determined by PCR on DNA isolated from tail 
biopsies (Supplemental Table 1).
Antibodies. Anti-REEP1 antisera were raised by immunization of rabbits 
against the peptide GRSSGKHSQPKMSRS (residues 176–190) (Eurogen-
tech) and affinity purified as described (34). Other primary antibodies used 
were: rabbit anti–β-actin (Abcam); mouse anti-TIM23 (BD Biosciences); 
rabbit anti-TUBB3 (β3-tubulin; Sigma-Aldrich); mouse anti–γ-adaptin (BD 
Transductions); rabbit anti–reticulon-4 (Aviva Systems Biology); mouse anti-
SMI312 (Hiss Diagnostics); mouse anti-NeuN (Millipore); rabbit anti–phos-
pho-tau (Biozol Diagnsotika); mouse anti-MAP2ab (Acris Antibodies); and 
rabbit anti-HisTrx antibodies raised and affinity purified as described (35).
Gait analysis. The foot-base angle at toe-off positions of the hind paws 
was quantified using single video frames from recordings of beam-walk-
ing mice (36). Statistical analyses were performed using two-way ANOVA. 
A skilled walking challenge was imposed by an inclined ladder (rung dis-
tance: 2 cm; rung thickness: 2 mm; rung width: 6 cm; inclination: 45°) (37) 
and evaluated qualitatively.
Histological analysis of spinal cord and brain. For immunohistochemical 
analysis of the motor cortex in 13-month-old Reep1+/+ and Reep–/–animals, 
neuronal cell bodies were visualized by NeuN staining of 20-μm sagit-
tal cryosections (n = 6 per genotype) and quantified layerwise. For semi- 
and ultrathin sectioning, animals were perfused with 50 ml fixative (4% 
paraformaldehyde, 1% glutaraldehyde). The brain and spinal cord were 
removed and postfixed overnight. Coronal sections (150 μm) were cut 
with a vibratome (Leica Microsystems) and processed as described (38). 
Semithin sections were stained with methylene blue. Ultrathin 80-nm sec-
tions (Ultratome III; LKB Instruments) were mounted on filmed copper 
grids (100 mesh), poststained with lead citrate, and studied using a TEM 
(EM 900; Zeiss) at 80 kV.
Quantitative analysis of electron microscopy images. For morphometry, only 
sections of somata of pyramidal neurons not extending beyond the image 
boundary and hit vertically in respect to the nuclear envelope were selected. 
Files were uploaded using ImageJ software (NIH), and the cell boundary, 
the nucleus, and the complete set of sheet-like ER structures were traced 
for each cell with a touch-sensitive pen screen system. The sphericity of the 
nucleus was calculated as the area of the nucleus divided by the area of a 
circle within the given perimeter. Data were obtained for four 12-month-
old animals per genotype and 12 neurons per animal. Statistical analyses 
were performed using one-way ANOVA.
Electromyographical analysis. Evoked CMAP amplitudes were evaluated as 
described (22). Statistical analyses were performed using two-way ANOVA.
In situ hybridization. As a probe template, a murine Reep1 cDNA fragment 
was amplified and cloned into pCRII-TOPO (Invitrogen). Radioactive (39) 
and nonradioactive (21) in situ hybridizations were carried out as described.
Analysis of axon outgrowth and ER stress in neuron cultures. Axon length in 
5-day-old spinal cord motor neuron cultures from E12.5 embryos was 
determined as reported previously (40). Cortical neurons and glia cells were 
prepared from P0 or P1 animals and cultured as described (41). Cells were 
thought to both insert into highly curved membranes as wedges. 
REEP1 is set apart from the reticulons and REEP5/Yop1p because 
of its shorter N-terminal hydrophobic domain (11, 12, 27). Our 
data show that the second, longer hydrophobic domain is suffi-
cient and its integrity critical for the shaping activity of REEP1.
In order to gain insights for the first time into the pathophys-
iology of REEP1 deficiency at the subcellular level in vivo, we 
conducted a detailed morphometric analysis of the ER in layer V 
neurons of the motor cortex, i.e., a region in which wild-type mice 
show particularly strong Reep1 expression. Quantitative evalua-
tions showed that the number of ER structures was decreased in 
both Reep1+/– and Reep1–/– mice, whereas the length of individual 
ER compartments was increased. Reduced ER complexity corre-
sponds to a reduced abundance of sharply curved ER membrane 
surfaces such as those found at the rims of ER sheets, at fenestrae, 
and at tubules. These dynamic ER substructures have a positive 
curvature with a relatively uniform diameter of about 35 to 40 
nm (28). This value strikingly mirrors our in vitro finding that 
liposomes with diameters of about 40 nm are the most abundant 
in the presence of REEP1. Supporting this, RNAi-based knock-
down of the Drosophila reticulon Rtnl1 in epidermal cell cultures 
was recently reported to increase the size of ER structures (29). 
As reticulons have also been suggested to bend membranes, these 
observations may correspond to reduced ER membrane curvature 
similar to the effects we observed upon REEP1 knockout.
Layer V motor neurons project over an extremely long distance 
onto spinal cord motor neurons, thus it is conceivable that these 
neurons depend on a particularly elaborate ER to maintain their 
long axonal extensions. This is supported by evidence that proteins 
implicated in three other major types of dominant HSPs are also 
linked to the ER: ATL1, mutated in SPG3A, encodes ATLASTIN1, 
which was shown to directly interact with tubule-shaping pro-
teins to promote homotypic fusion of ER membranes and main-
tain proper ER network formation (30, 31). SPAST, mutated in 
SPG4, encodes SPASTIN, a protein that was shown to interact 
with ATLASTIN1 and REEP1 and organizes the structure of the 
ER by connecting it to microtubules (11). Finally, RTN2, which is 
mutated in SPG12 (32), encodes a protein of the reticulon family 
that has been shown to reside in and shape the ER (29).
Thus, REEP1 knockout in mice and comparison with the clin-
ical, neurodegenerative phenotype of the autosomal dominantly 
inherited HSP variant SPG31 revealed that loss of REEP1 leads to 
defects in ER organization. Whether an altered ER complexity may 
also interfere with ER functions like the unfolded protein response 
and/or specific ER export functions are  important questions to 
address in the future.
Methods
REEP1 copy number screening in HSP patients. Eighty-seven index patients 
from Spanish families with dominant HSP were enrolled (33). MLPA was 
performed according to the manufacturer’s instructions using the SALSA 
P213 probe mix (MRC-Holland). The sample with the aberrant signals 
for exon 2 was subjected to long-range PCR, applying a forward primer in 
intron 1 and a reverse primer in intron 2, and was subsequently sequenced 
(Supplemental Table 1).
Modeling Reep1 exon 2 deletion in mice. An 8.3-kb fragment of a 129/SvJ 
mouse genomic λ library (Stratagene) including exons 2 and 3 and neigh-
boring intronic sequences was cloned into the pKO-V901 plasmid (Lexi-
con Pharmaceuticals) containing a phosphoglycerate kinase (PKG) pro-
moter-driven diphtheria toxin A cassette using BamHI and SalI sites. One 
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sucrose for 15 minutes at 37°C. To avoid liposomal aggregates, 20 μg 
proteinase K was subsequently added, followed by another incubation at 
45°C for 40 minutes. Small aliquots (1–2 μl) of vesicle suspension were 
freeze-fractured as described (41). Immunogold labeling at freeze-fracture 
replicas without proteinase K incubation was done using specific anti-
REEP1 primary antibodies (1:50) followed by a gold-conjugated secondary 
antibody (1:50, 10 nm gold; British Biocell International). The samples 
were examined using an EM 902 A electron microscope (Zeiss). Images 
were acquired using a 1k FastScan CCD camera (TVIPS). Diameters of 
900–1,300 liposome structures per incubation condition were determined 
using ImageJ software.
Statistics. One-way ANOVA was used for comparisons between three groups 
(for liposome diameters and for the ultrastructural analysis of ER structures). 
A two-tailed Student’s t test was used for comparison between two groups 
(axon outgrowth and quantification of cortical neurons). For the analysis of 
repeated measurements over time, two-way ANOVA was applied (gait analy-
sis, CMAP analysis). P ≤ 0.05 was considered statistically significant.
Study approval. All animal experiments were approved by the local admin-
istrative institution (Thüringer Landesamt für Verbraucherschutz, Bad 
Langensalza, Germany). Written informed consent was obtained from the 
patients for genetic studies.
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fixed after 3 days in culture and stained for F-actin and immunostained 
with antibodies against the pan-axonal neurofilament marker SMI312. 
Images of neurons were acquired at ×40 magnification (Axioplan2; Zeiss), 
and axon length was measured using ImageJ software. Statistical analyses 
were performed using the Student’s t test.
Subcellular fractionation. Four wild-type mice were sacrificed and tissues 
immediately removed and snap-frozen at –80°C. Tissues were ground 
using a precooled mortar and pestle and homogenized using a glass- 
Teflon device (Braun Biotech) as described (34). Subcellular fractions were 
obtained by differential centrifugation at 4°C (10 minutes at 1,000 g to pel-
let nuclei, 15 minutes at 10,000 g to pellet mitochondria, 1 hour at 100,000 g 
to pellet the membrane fraction). The postmitochondrial fraction was fur-
ther fractionated by a discontinuous iodixanol gradient, and individual 
fractions were diluted, pelleted, resolved in SDS sample buffer (42), and 
quantitatively evaluated by fluorescence-based immunoblotting using a 
LI-COR Odyssey system.
Purification of recombinant REEP1. The coding sequence of human REEP1, 
including the stop codon, was amplified from brain-derived cDNA (Clon-
tech) and cloned into the pET32-a vector (Novagen). From this construct 
(HisTrx-REEP1), the construct for the HisTrx-REEP1-mut variant was 
generated by PCR mutagenesis–mediated introduction of four single base 
alterations (p.I57S, p.F58S, p.F62S, and p.F64S). His-tagged fusion pro-
teins were purified from E. coli as described (35).
Liposome cofloatation assay. Liposomes were prepared as described (43). 
Liposomes (150 μg) were incubated with 0.5 μM protein for 15 minutes at 
37°C in 0.3 M sucrose in liposome buffer (25 mM HEPES-KOH, pH 7.2; 
25 mM KCl; 2.5 mM Mg-acetate; 100 mM K-glutamate) and mixed with 150 μl 
75% sucrose in liposome buffer. The mixture was overlaid with 200 μl 35% 
sucrose and 200 μl liposome buffer and then centrifuged at 200,000 g for 
30 minutes at 28°C. Six fractions containing 100 μl eluate each were col-
lected from top to bottom and analyzed by SDS-PAGE and immunoblotting.
Live imaging of liposome-protein mixtures. Liposomes were supplemented 
with 5% rhodamine PE (Avanti Polar Lipids), incubated with 0.1 μM of the 
recombinant proteins at room temperature for 10 minutes, and visualized 
(Zeiss Observer Z1; Zeiss). Images were acquired every 200 milliseconds 
over a period of 2 minutes.
Liposome-shaping assay. For freeze-fracture experiments, 1 mg of liposomes 
was incubated with 5 μM protein in liposome buffer containing 0.3 M 
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